Related Experiment Videos
Presenilin-1 expression in Pick's disease.
P Giannakopoulos1, E Kövari, L Buée
1Department of Psychiatry, Clinic of Geriatric Psychiatry, HUG Belle-Idée, University of Geneva School of Medicine, CH-1225 Geneva, Switzerland. giannako@cmu.unige.ch
Acta Neuropathologica
|December 14, 1999
Summary
Low presenilin-1 (PS-1) expression is linked to neuronal vulnerability in Alzheimer's disease. This study finds similar patterns in Pick's disease, suggesting PS-1 levels are critical for neuronal survival across neurodegenerative conditions.
Area of Science:
- Neuroscience
- Neuropathology
Background:
- Neuronal populations with low presenilin-1 (PS-1) expression show increased vulnerability in Alzheimer's disease (AD).
- The role of PS-1 in other neurodegenerative diseases remains less understood.
Purpose of the Study:
- To investigate the distribution and levels of PS-1 in the cerebral cortex of individuals with Pick's disease (PiD).
- To determine if reduced PS-1 expression is associated with neuronal loss in PiD, similar to AD.
Main Methods:
- Quantitative immunocytochemistry was used to study PS-1 distribution in neurons.
- Immunoblotting quantified PS-1 levels in cortical tissue.
- Comparison was made between PiD cases and non-demented individuals.
Main Results:
- In PiD cases, a higher percentage of PS-1-containing neurons lacking Pick bodies (PBs) was observed in areas with significant neuronal loss.
- Cortical PS-1 levels were often elevated in PiD compared to controls.
- Neurons containing PBs exhibited significantly reduced PS-1 immunoreactivity.
Conclusions:
- Reduced cellular PS-1 expression is associated with increased neuronal loss and degeneration in Pick's disease.
- These findings extend the observation from AD, highlighting a potential common mechanism in neurodegeneration involving PS-1.
- PS-1 levels and distribution are critical indicators of neuronal health in neurodegenerative disorders.